mBioWorks ApS: Financial statements 2023
CVR: 43186957
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
mBioWorks ApS (CVR 43186957) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 57,949 and a net result of DKK 24,537. The profit margin was 42.3%. Equity in the 2023 report amounted to DKK 354,549. The solvency ratio was 74.7%.
- Revenue
- DKK 57,949
- Gross Profit
- DKK 57,949
- Profit/Loss
- DKK 24,537
- Equity
- DKK 354,549
- Total Assets
- DKK 474,594
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MBioWorks ApS has published its interim report for the period April 7, 2022 – December 31, 2022.
About mBioWorks ApS
mBioWorks ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Yonghui Zeng. The company is owned by Yonghui Zeng. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 76,775 and a net result of DKK 17,506 compared with DKK -122,969 the year before. Equity in the 2025 report amounted to DKK 256,690.